FLORHAM PARK, N.J., July 11, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today the availability of prescription drug assistance programs to reduce health insurance co-payments for six primary dermatological brands. Under the programs, patients will pay $10 - $30 out-of-pocket for ADOXA® 150mg (doxycycline capsules), APEXICON® E (diflorasone diacetate USP 0.05% [emollient]) CREAM, CUTIVATE® (fluticasone propionate) LOTION, 0.05%, OXISTAT® (oxiconazole nitrate) CREAM, 1% and LOTION, 1%, SOLARAZE® (diclofenac sodium) Gel, 3%, and VEREGEN® (sinecatechins) Ointment, 15%.
The programs reduce the patient's out-of-pocket costs through the use of Instant Savings Cards. These cards can be obtained directly from a doctor's office and are used in conjunction with a valid prescription. Patients present the card to their pharmacist when filling the prescription and have their co-pay or out-of-pocket cost reduced.
"PharmaDerm listens to our community of physicians and patients to help us assess their challenges and potential obstacles to treatment. We recognize that one such challenge involves prescription co-pay expenses, which may be prohibitive for some insured patients," said Steve Andrzejewski, CEO of Nycomed US. "The co-pay assistance programs demonstrate our commitment to being responsive to the needs of both the prescribers and the users who may benefit from our medications, which treat some of the more common skin conditions affecting patients today."
Any individual with prescription drug benefits coverage requiring a patient co-payment is eligible to participate in the programs. Terms and conditions (e.g., co-pay amount, eligibility requirements, limits on number of prescriptions and prescription refills, program activation and expiration dates) vary by product.
To learn more about the co-pay assistance programs and to obtain Instant Savings Cards, physicians can cont
Copyright©2010 PR Newswire.
All rights reserved